ClinicalTrials.gg
RecruitingNCT06829758SoledadLPUpdated Feb 28, 2025

Compartiendo Salud: Community-Based Intervention for Loneliness

An interventional study of Compartiendo Salud in Loneliness, sponsored by Servicio Canario de Salud. Recruiting at 1 site in Spain. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2025-02-28.

Sponsored by Servicio Canario de Salud · Not applicable, Interventional, and Health services research

How we know

From the registry’s dates

  • Primary completion was expected by Dec 2025, 11 months ago, but the record still lists the study as recruiting.
  • Registered 1 year 11 months after the study started (first participant enrolled Mar 2023, registered Feb 2025).
  • Started Mar 2023; still recruiting 3 years 8 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
300
Allocation
Not applicable
Ages
65 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 49 studies in Health Education with a site in Spain — 18 open to participants now, 19 under way, none of them phase 3. Health Education · Spain.

Planned enrollment
11th of 47
300 · median 168
Started
2023
with 7 others
No phase
44 of 49
17 open now
Primary completion
2025-12
later than 7 of 18 live
Registered
32nd of 49
by date

Among the 49 studies in Health Education with a site in Spain, this one is the 11th largest by planned enrollment of the 47 interventional ones that give a count, is one of 8 that started in 2023, is one of 44 with no phase, reaches primary completion later than 7 of the 18 other live ones, and was the 32nd registered.

Health Education

491 studies on the registry are indexed under Health Education; 118 are open to participants now.

Browse Health Education studies →

Open to participants now

18 of the 49 studies in Health Education with a site in Spain are open now. Recruiting first, the newest first:

12 more — sign in →

All 18 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 48 Health Education studies recruiting now, 31 (65%) set no upper age limit and 14 (29%) stop at 75 or younger; 12 take children under 18; 20 take healthy volunteers.

This study: 65 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 49 studies in Health Education with a site in Spain, or all of them as a file.
02

Study summary

Unwanted loneliness is the gap between the social relations a person has and those they want. The main objective of this research is to assess the impact of a multidimensional community-based intervention on the feeling of unwanted loneliness in the population over the age of 65 years old, who living alone, under social risk or socially isolated living in the La Palma island.

Read the detailed description

Loneliness is strongly associated with a significant impact on physical health, depression and may in fact be an independent risk factor for depression. Fur-thermore, it is negatively associated with healt problems, like higher blood pressure, poorer sleep, immune responses to stress, and poorer cognition over time in the elderly. The absence of personal connections is related to the adoption of worse life habits and to increased morbidity, with the consequent higher risk of suf-fering cardiovascular and endocrine diseases, mental health pathologies and risk of falls.

The secondary objectives proposed are as follows: Increasing the number of opportunities for social interaction during the intervention; Contributing tools to improve the participants' social skills in the intervention; Fostering self-care and healthy habits in the participants; Reducing maladaptive thoughts; Educating on sleep hygiene measures and non-pharmacological treatments.

The null hypothesis (H0) of this research is that in the population under study, the proposed multidimensional community intervention will not significantly impact the feeling of unwanted loneliness and the health management of these subjects.

03

Conditions studied

  • Loneliness

Browse trials for

Keywords

  • Social Support
  • Community Health Nursing
  • Health Education
  • Aged
04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • People over the age of 65 and living alone
  • Nursing diagnosis of social risk
  • Nursing diagnosis of social isolation

Exclusion criteria

Exclusion Criteria:

  • presenting moderate/severe cognitive decline or Pfeiffer scores above 6
  • individuals with uncorrected hearing deficits that hinder group interaction
  • participants not subjected to the pre- and post-interventions measurements
  • participants that do not take part in at least four of the five sessions scheduled
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
300 participants (estimated)

Study arms

  • Experimental
    Intervention

    The intervention proposed (Compartiendo Salud) is a multicomponent intervention based on prevention and on promoting the health of older adults that live alone. Quasi-experimental study was designed with pre- and post- intervention (at three months) measurements, with no Control Group or randomisation.

    Behavioral: Compartiendo Salud

Interventions

  • BehavioralCompartiendo Salud

    The intervention proposed (Compartiendo Salud) is a multicomponent intervention based on prevention and on promoting the health of older adults that live alone. The community-based intervention consists in five workshops that are carried out during a week (one day for each workshop). The sessions (which last 2.5 hours each) are designed in an expository and participatory way, using gaming dynamics that foster learning and social interaction. The content of the workshops is the same for all BHDs. Each workshop addresses risk factors that predispose the population to experiencing more unwanted loneliness and social isolation. The concepts corresponding to each of the five sessions that comprise the intervention are: Sleep hygiene, Healthy and sustainable eating habits, Physical activity and exercise, Memory and music therapy, Digital literacy

06

What researchers measure

Primary outcomes

  1. Number of Participants with Feeling of unwanted loneliness

    It was measured using the "UCLA (University of California at Los Angeles) Loneliness scale" test validated in Spain. This instrument is based on three dimensions: Relational connection; Social connection; and Self-perceived isolation. It uses a 4-point scale ranging from "Never" to "Frequently" for responses 10 items. Scores above 30 correspond to "No loneliness", between 20 and 30 mean "Moderate loneliness" and less than 20 points is "Severe loneliness"

    Time frame: Pre- and post- intervention (at three months)

Secondary outcomes

  1. Number of Participants with Social risk

    It was measured using the Gijón Social risk detection questionnaire. It assesses family and economic situations, housing, social relations and support from social networks. It uses a 5-point scale ranging from best to worse situation, for responses 5 items. Scores: Good/Acceptable social situation: from 5 to 9 points; Social risk: from 10 to 14; and social problem: more than 15

    Time frame: Pre- and post- intervention (at three months)

  2. Number of Participants with Low Perceived social support

    It was measured with Duke's questionnaire. It assesses perceived social support and consists of 11 items, each one assessed with a Likert scale from 1 to 5. Scores equal to or higher than 32 indicate "Normal support", whereas less than 32 points means "Low perceived social support"

    Time frame: Pre- and post- intervention (at three months)

  3. Number of Participants with Anxiety or depression

    They were assessed using Goldberg's questionnaire with two subscales: Anxiety and Depression. Each of them is structured with 4 initial screening items to determine the probability of a mental disorder and a second group with 5 items that are only formulated if positive answers are given to the screening questions (at least 2 in the Anxiety subscale and at least 1 in the Depression subscale). The type of response of the questionnaire is dichotomous (Yes/No). The cut-off points are as follows: scores equal to or higher than 4 for the Anxiety subscale; and values equal to or higher than 2 for Depression. In the geriatric population, it has been proposed to use it as a single scale, with a cut-off point equal to or higher than 6

    Time frame: Pre- and post- intervention (at three months)

  4. Number of Participants with Risk of loneliness

    Nursing diagnosis "Risk of loneliness" (Yes/No) and presence/absence of each of its defining characteristics: Affective deprivation; Emotional Deprivation; Physical isolation; Social isolation.

    Time frame: Pre- and post- intervention (at three months)

  5. Number of Participants with Social Isolation

    Nursing diagnosis "Social Isolation" (Yes/No) and presence/absence of each of its defining characteristics: Low social activity levels; Change in physical aspect; Explicit dissatisfaction with social connections; Social reclusion; Social behaviour inconsistent with cultural norms; Reporting feeling insecure in public; Reduced eye contact.

    Time frame: Pre- and post- intervention (at three months)

  6. Number of Participants with Smoking

    The smoking assessment included in the habits module of the electronic clinical history of Primary Health Care of the Canary Islands Health Service Drago-AP will be used: Non-smoker/Smoker in undetermined phase/Smoker in pre-contemplation phase (consonant)/Smoker in contemplation phase (dissonant)/Smoker in preparation phase/Smoker in action phase/Smoker in maintenance phase/Former smoker since 1-10 years/Former smoker since more than 10 years/Passive smoker

    Time frame: Pre- and post- intervention (at three months)

  7. Number of Participants with alcoholism

    The alcoholism assessment included in the habits module of the electronic clinical history of Primary Health Care of the Canary Islands Health Service Drago-AP will be used: Non-drinker/Moderate drinker/Risk drinker/Drinking problem

    Time frame: Pre- and post- intervention (at three months)

  8. Number of Participants without sleep problems

    Sleep problem (Yes/No)

    Time frame: Pre- and post- intervention (at three months)

  9. Number of Participants with caregiver

    Dichotomous variables (Yes/No)

    Time frame: Pre- and post- intervention (at three months)

  10. Number of Participants belonging to an organized group

    Dichotomous variables (Yes/No)

    Time frame: Pre- and post- intervention (at three months)

  11. Number of Participants what does it feel like Integrated in the area where they live

    Dichotomous variables (Yes/No)

    Time frame: Pre- and post- intervention (at three months)

  12. Number of Participants with Activities in free and/or leisure time

    Dichotomous variables (Yes/No)

    Time frame: Pre- and post- intervention (at three months)

  13. Number of Participants with Home-based care; Social assistance

    Dichotomous variables (Yes/No)

    Time frame: Pre- and post- intervention (at three months)

07

Study locations

1 of 1 sites recruiting
  • La Palma Health Area. Canary Islands Health Service.
    Santa Cruz de La Palma, Spain
    Recruiting
08

References and documents

Individual participant data

Plan to share: Yes — Data will be available upon reasonable request. The data to be shared will include all IPD that underlie results in a publication, as well as the statistical analysis plan, informed consent form and the analytic code. All sensitive data will be anonymized to ensure the privacy and confidentiality of the participants.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Analytic code

Time frame: The complete IPD will be available for sharing six months after the study's conclusion.

Access criteria: As an access criterion for Individual Participant Data (IPD), it is required that no information be requested that could compromise the anonymity of participants. This ensures adherence to ethical research standards and the protection of personal data, safeguarding the confidentiality and privacy of all individuals involved.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2023 (actual). Primary completion is estimated for Dec 2025, 33 months after the start.

Of 296 non-industry interventional studies with no phase under Health Education, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 24. This study's planned 33 months is above that.

Counting every sponsor, half of 297 studies reached it within 11 months; a quarter within 3 and three quarters within 24.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 10, 2025
First posted
Feb 17, 2025
StartActual
Mar 1, 2023
Primary completionEst.
Dec 2025
CompletionEst.
Dec 2025
Last update
Feb 28, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 28, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06829758
Lead sponsor
Servicio Canario de Salud
Collaborators
University of La Laguna
Responsible party
Sponsor
First posted
Feb 17, 2025
Start date
Mar 1, 2023
Primary completion
Dec 2025 (estimated)
Completion
Dec 2025 (estimated)
Last update
Feb 28, 2025

Study contacts

Alba Francisco-Sánchez, Nursing Specialist
Contact
afrasanb@gobiernodecanarias.org
34922479460
Martín Rodríguez-Álvaro, PhD
Contact
mrodrigu@ull.edu.es
34922479460
Alba Francisco-Sánchez, Nursing Specialist
principal investigator · Atención Primaria. Área de Salud de La Palma. Servicio Canario de Salud

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion